SEQ-9 is an orally active Mycobacterium tuberculosis ( Mtb ) 23S bacterial ribosome inhibitor with an IC 50 of approximately 170 nM for unmethylated Mtb ribosomes. SEQ-9 also potently inhibits A2296 methylated ribosomes. SEQ-9 can be used to study bacterial infection and drug resistance.